Traveka Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
6,397
+153
+2% +$35.7K 0.54% 42
2026
Q1
$1.53M Buy
6,244
+303
+5% +$70.6K 0.58% 40
2025
Q4
$1.23M Sell
5,941
-1,010
-15% -$200K 0.5% 44
2025
Q3
$1.29M Buy
6,951
+331
+5% +$56.7K 0.58% 38
2025
Q2
$1.01M Sell
6,620
-1,129
-15% -$174K 0.54% 39
2025
Q1
$1.29M Buy
7,749
+1,382
+22% +$216K 0.72% 37
2024
Q4
$921K Buy
6,367
+4,353
+216% +$675K 0.51% 43
2024
Q3
$326K Sell
2,014
-84
-4% -$13.4K 0.17% 88
2024
Q2
$307K Sell
2,098
-851
-29% -$127K 0.15% 83
2024
Q1
$467K Sell
2,949
-4,706
-61% -$749K 0.22% 60
2023
Q4
$1.2M Buy
+7,655
New +$1.17M 0.6% 37

Other funds holding JNJ

Traveka Wealth's JNJ Position: Q2 2026 in Review

Traveka Wealth increased its Johnson & Johnson (JNJ) stake by 2.5% in Q2 2026, buying an estimated $35.7K and bringing the position to 6,397 shares worth $1.62M. The position accounts for 0.54% of the portfolio, ranked #42.

Traveka Wealth first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,509 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Traveka Wealth held 6,397 shares of Johnson & Johnson worth $1.62M as of Q2 2026.
  • Traveka Wealth bought 153 Johnson & Johnson shares in Q2 2026, an estimated $35.7K.
  • Johnson & Johnson made up 0.54% of Traveka Wealth's portfolio in Q2 2026, its #42 holding.
  • Traveka Wealth first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,509 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.